Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance March 24, 2026 at 7:00 AM EDT
Our MissionSanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative products to improve clinical outcomes and reduce healthcare expenditures in the surgical market. Investor Presentation Minimum 15 minutes delayed. Source: LSEG News Releases March 24, 2026 Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance March 11, 2026 Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds March 3, 2026 Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 All News Releases Events March 24, 2026 | 8:00 AM EDT Fourth Quarter 2025 Results and Business Update March 3, 2026 | 9:10 AM EST TD Cowen 46th Annual Health Care Conference December 12, 2025 MicroCap Club Business Breakdowns Podcast All Events Show all All Quarterly Results Latest Annual Report & Proxy 2024 Annual Report 2024 Proxy Statement
March 24, 2026 Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance
March 11, 2026 Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
March 3, 2026 Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
